Neuroone Medical Technologies (NMTC) Net Equity Issued and Repurchased (2013 - 2026)
Neuroone Medical Technologies' (NMTC) quarterly Net Equity Issued and Repurchased came in at $9.2 million in Q2 2025, up 446.5% YoY from $1.7 million in Q2 2024, and up 319.2% on a QoQ basis from -$4.2 million in Q3 2024.
Neuroone Medical Technologies (NMTC) Net Equity Issued and Repurchased (2013 - 2026) Analysis & Trends
Neuroone Medical Technologies (NMTC) has 5 years of Net Equity Issued and Repurchased data on file, last reported at $9.2 million in Q2 2025.
- Quarterly Net Equity Issued and Repurchased rose 446.5% year-over-year to $9.2 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $8.8 million (up 62.54% YoY) and the FY2024 annual result came in at $836777.0, down 67.22% from the prior year.
- Net Equity Issued and Repurchased advanced to $9.2 million in Q2 2025, from -$4.2 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $9.2 million in Q2 2025 to a low of -$4.2 million in Q3 2024.
- A 4-year average of $1.7 million and a median of $1.7 million in 2023 frame the typical range for Net Equity Issued and Repurchased.
- Annual changes were most pronounced in 2024 — Net Equity Issued and Repurchased climbed 3.63% — and 2025, when it surged 446.5%.
- Tracing NMTC's Net Equity Issued and Repurchased over 4 years: stood at -$1.3 million in 2021, then soared by 387.04% to $3.8 million in 2023, then sank by 210.19% to -$4.2 million in 2024, then soared by 319.2% to $9.2 million in 2025.
- The last three Net Equity Issued and Repurchased figures came in at $9.2 million (Q2 2025), -$4.2 million (Q3 2024), and $1.7 million (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | - |
| 10 | Neuroone Medical Technologies | 17.95 Mn | 15.91 Mn | 1.18 Mn | 358,986.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 358,986.00 |
| Jun 30, 2026 | 358,986.00 |
| Jun 30, 2025 | 9.20 Mn |
| Jun 30, 2025 | 9.20 Mn |
| Sep 30, 2024 | -4.20 Mn |
| Sep 30, 2024 | -4.20 Mn |
| Jun 30, 2024 | 1.68 Mn |
| Jun 30, 2024 | 1.68 Mn |
| Mar 31, 2024 | 2.09 Mn |
| Mar 31, 2024 | 2.09 Mn |
| Dec 31, 2023 | 3.81 Mn |
| Dec 31, 2023 | 3.81 Mn |
| Jun 30, 2023 | 1.62 Mn |
| Jun 30, 2023 | 1.62 Mn |
| Mar 31, 2023 | 516,484.00 |
| Mar 31, 2023 | 516,484.00 |
| Dec 31, 2021 | -1.33 Mn |
| Dec 31, 2021 | -1.33 Mn |
| Jun 30, 2013 | 7,000.00 |
| Jun 30, 2013 | 7,000.00 |